Objective: To evaluate the use of the levonorgestrel intrauterine system (LNG-IUS) in obese premenopausal women with abnormal uterine bleeding (AUB).
Design: Prospective observational study (Canadian Task Force Classification II-2).
Setting: University-affiliated teaching hospital.
Objective: To evaluate the efficacy of levonorgestrel intrauterine systems (LNG-IUS) in obese women with AUB on anticoagulant therapy.
Design: Prospective observational case series (Canadian Task Force Classification II-3).
Setting: University affiliated teaching hospital.